PT  - JOURNAL ARTICLE
AU  - Ray, Avik
AU  - Sharma, Swati
AU  - Sadasivam, Balakrishnan
TI  - Carbovigilance: curtailing the global pharmaceutical carbon footprint
AID  - 10.7861/fhj.2021-0071
DP  - 2021 Nov 01
TA  - Future Healthcare Journal
PG  - e683--e685
VI  - 8
IP  - 3
4099  - http://www.rcpjournals.org/content/8/3/e683.short
4100  - http://www.rcpjournals.org/content/8/3/e683.full
SO  - Future Healthc J2021 Nov 01; 8
AB  - Cutting emissions from the pharmaceutical industry is essential to curtailing the carbon footprint of healthcare globally. It is high time that the industry owned up to its carbon emission and took measures to curb back. In this study, we show how many of the leading global pharmaceutical firms have been able to reduce their carbon footprint while being profitable, indicating that modifications to reduce emissions would not pose a financial burden. We have come up with a ‘modified emission intensity’ index and a new term ‘carbovigilance’ in an attempt to bring this aspect of the pharmaceutical companies to light, while also encouraging them to work towards making positive contributions to a greener and healthier earth.